Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–186.
PubMed Web of Science ®Google Scholar
Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174–180.
PubMed Web of Science ®Google Scholar
Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther. 2015;32(10):875–887.
PubMed Web of Science ®Google Scholar
Terrell DR, Beebe LA, Neas BR, et al. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012;87(9):848–852.
PubMed Web of Science ®Google Scholar
Kuhne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr. 2003;143(5):605–608.
PubMed Web of Science ®Google Scholar
Warrier R, Chauhan A. Management of immune thrombocytopenic purpura: an update. Ochsner J. 2012;12(3):221–227.
PubMedGoogle Scholar
Neunert CE. Current management of immune thrombocytopenia. Hematology. 2013;2013(1):276–282.
PubMedGoogle Scholar
Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–4207.
PubMed Web of Science ®Google Scholar
Tarantino MD, Danese M, Klaassen RJ, et al. Hospitalizations in pediatric patients with immune thrombocytopenia in the United States. Platelets. 2016;27(5):472–478.
PubMed Web of Science ®Google Scholar
Chalmers S, Tarantino MD. Romiplostim as a treatment for immune thrombocytopenia: a review. J Blood Med. 2015;6:37–44.
PubMed Web of Science ®Google Scholar
Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med. 2005;56:425–442.
PubMed Web of Science ®Google Scholar
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393.
PubMed Web of Science ®Google Scholar
Nplate [package insert]. Thousand Oaks (CA): Amgen Inc.; 2017.
Google Scholar
Promacta [package insert]. East Hanover (NJ): Novartis AG; 2017.
Google Scholar
Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr (Phila). 2004;43(8):691–702.
PubMed Web of Science ®Google Scholar
Wu SR, Kuo HC, Huang WC, et al. Incidence, clinical characteristics, and associated diseases in patients with immune thrombocytopenia: a nationwide population-based study in Taiwan. Thromb Res. 2018;164:90–95. Apr
PubMed Web of Science ®Google Scholar
Moulis G, Palmaro A, Montastruc JL, et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308–3315.
PubMed Web of Science ®Google Scholar
Schoonen WM, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009;145(2):235–244.
PubMed Web of Science ®Google Scholar
Koylu A, Pamuk GE, Uyanik MS, et al. Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey. Ann Hematol. 2015;94(3):459–466.
PubMed Web of Science ®Google Scholar
Frederiksen H, Schmidt K. The Incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94(3):909–913.
PubMed Web of Science ®Google Scholar
Kime C, Klima J, Rose MJ, et al. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children’s hospitals. Pediatrics. 2013;131(5):880–885.
PubMed Web of Science ®Google Scholar
Danese MD, Lindquist K, Gleeson M, et al. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol. 2009;84(10):631–635.
PubMed Web of Science ®Google Scholar
An R, Wang PP. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012. VHRM. 2017;13:15–21.
Google Scholar
Mezaache S, Derumeaux H, Ferraro P, et al. Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database. Eur J Haematol. 2017;99(4):344–349.
PubMed Web of Science ®Google Scholar
Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4(11):2377–2383.
PubMed Web of Science ®Google Scholar
Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol. 2004;75(1):12–17.
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature